A Pfizer whistleblower has come forward with claims that the company provided a “separate and distinct” COVID-19 vaccine to its employees at the Pearl River research facility in Rockland County, New York, according to InfoWars. An internal email dated January 2021 has surfaced, suggesting that Pfizer reassured employees that this special vaccine supply would not interfere with the doses allocated to national governments globally.
The internal communication detailed that “site-essential” workers at the facility were selected to receive this exclusive vaccine variant. This has raised questions among Pfizer employees, with the whistleblower telling InfoWars, “I know we employees at Pfizer were receiving different vaccines and/or placebos, and this was the word around my site when I worked there.”
Don’t miss this! Carry faith with you everywhere with the Exclusive National Prayer Coin!
The email provided to employees stated: “I am pleased to inform you that we will begin offering COVID-19 vaccinations to eligible on-site essential colleagues and contractors over the next several weeks… The vaccine doses to be used for this program are separate and distinct from those committed by Pfizer to governments around the world and will not impact supply to national governments in any way.”
This initiative was not limited to the New York site alone. Pfizer’s plant in Newbridge, County Kildare, Ireland, also reportedly participated, with several hundred employees receiving what was confirmed as the Pfizer/BioNTech vaccine. Local reports from Kildare Live in 2021 highlighted that the vaccination of “site-essential” staff would not affect the broader vaccine rollout managed by the health service.
Pfizer responded to these claims by explaining the rationale behind vaccinating site-essential personnel, which included those involved in manufacturing and R&D crucial for maintaining the supply of medicines and vaccines. “Vaccination of site-essential employees started this week at our manufacturing sites in Kalamazoo, Michigan, and Puurs, Belgium. We will expand to other Pfizer sites on a rolling basis,” the company stated, asserting that around 15,000 employees and contractors across Pfizer sites in the EU were deemed essential for these purposes.
